A new report published by Turning Point titled “A Sobering Thought”, spotlights the devastating impact of alcohol-related harm and calls for urgent action to address the issue. On this report, FibroScan® is highlighted for early detection of liver disease in primary and community care settings and improved access to testing for underserved groups.
Subscribe to our mailing list to receive updates on clinical articles, products and educational webinars of liver disease management based on your geographical localization.